BIODESIX INC Share Price Today: Live Updates & Key Insights

BIODESIX INC share price today is $21.56, up -1.43%. The stock opened at $22.72 against the previous close of $22.32, with an intraday high of $23.8 and low of $22.01.

BIODESIX INC Share Price Chart

BIODESIX INC

us-stock
To Invest in {{usstockname}}
us-stock

BIODESIX INC Share Price Performance

$21.56 -0.0143(-1.43%) BDSX at 27 Jul 2026 02:09 PM Diagnostics & Research
Lowest Today 22.01
Highest Today 23.8
Today’s Open 22.72
Prev. Close 22.32
52 Week High 24.92
52 Week Low 5.26
Day’s Range: Low 22.01 High 23.8
52-Week Range: Low 5.26 High 24.92
1 day return -
1 Week return +10.38
1 month return -4.28
3 month return +113.62
6 month return +119.12
1 year return +5163.03
3 year return +1806.03
5 year return +129.59
10 year return -

BIODESIX INC Institutional Holdings

AIGH Capital Management, LLC 7.32

abrdn Healthcare Opportunities 4.81

Telemark Asset Management, LLC 4.73

Aberdeen Group PLC 4.43

Soleus Capital Management, L.P. 4.02

Vanguard Capital Management, LLC 2.46

Opaleye Management Inc 2.30

Vanguard Total Stock Mkt Idx Inv 1.97

Vanguard Group Inc 1.86

Marshall Wace Asset Management Ltd 1.37

StemPoint Capital LP 1.35

Essex Investment Management Company, LLC 1.28

Vanguard Institutional Extnd Mkt Idx Tr 0.70

Trexquant Investment LP 0.67

1290 Essex Small Cap Growth I 0.57

Geode Capital Management, LLC 0.48

Two Sigma Investments LLC 0.44

Perkins Capital Management Inc 0.43

SEI Investments Co 0.42

Legato Capital Management LLC 0.40

GSA Capital Partners LLP 0.38

UBS Group AG 0.36

Morgan Stanley - Brokerage Accounts 0.31

Vanguard Fiduciary Trust Co 0.28

Pleiades Small Cap Equity A 0.21

Fidelity Extended Market Index 0.20

iShares Micro-Cap ETF 0.17

Bridgeway Ultra-Small Company Market 0.10

NT Ext Equity Mkt Index Fund - Lending 0.07

Blackrock Extended Mkt Fund CF 0.07

Extended Equity Market Fund B 0.07

Extended Equity Market Fund E 0.07

Fidelity Total Market Index 0.06

Vanguard Instl Ttl Stck Mkt Index Trust 0.06

BlackRock Extended Equity Market Fund K 0.06

NT Ext Equity Mkt Index Fund - NL 0.06

Fidelity Series Total Market Index 0.06

Spartan Extended Market Index Pool F 0.06

Fidelity Nasdaq Composite Index 0.05

Northern Trust Extended Eq Market Idx 0.05

BIODESIX INC Market Status

Strong Buy: 4

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

BIODESIX INC Fundamentals

Market Cap 231.14 M

PB Ratio 24.0978

PE Ratio 0.0

Enterprise Value 266.10 M

Total Assets 87.48 M

Volume 90555

BIODESIX INC Company Financials

Annual Revenue FY23:44026000 44.0M, FY22:38212000 38.2M, FY21:54506000 54.5M, FY20:45557000 45.6M, FY19:24552000 24.6M

Annual Profit FY23:31084000 31.1M, FY22:24058000 24.1M, FY21:23988000 24.0M, FY20:23559000 23.6M, FY19:18478000 18.5M

Annual Net worth FY23:-63345000 -63.3M, FY22:-80388000 -80.4M, FY21:-44480000 -44.5M, FY20:-36473000 -36.5M, FY19:-31355000 -31.4M

Quarterly Revenue Q1/2026:25555000 25.6M, Q3/2025:21768000 21.8M, Q2/2025:20018000 20.0M, Q1/2025:17958000 18.0M, Q3/2024:18151000 18.2M

Quarterly Profit Q1/2026:21350000 21.4M, Q3/2025:17662000 17.7M, Q2/2025:15987000 16.0M, Q1/2025:14255000 14.3M, Q3/2024:13972000 14.0M

Quarterly Net worth Q1/2026:-7793000 -7.8M, Q3/2025:-8716000 -8.7M, Q2/2025:-11468000 -11.5M, Q1/2025:-11101000 -11.1M, Q3/2024:-10258000 -10.3M

About BIODESIX INC & investment objective

Company Information Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Organisation Diagnostics & Research

Employees 334

Industry Diagnostics & Research

CEO Mr. Scott Hutton

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BIODESIX INC FAQs

What is the share price of BIODESIX INC today?

The current share price of BIODESIX INC is $21.56.

Can I buy BIODESIX INC shares in India?

Yes, Indian investors can buy BIODESIX INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy BIODESIX INC shares in India?

You can easily invest in BIODESIX INC shares from India by:

Can I buy fractional shares of BIODESIX INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BIODESIX INC?

BIODESIX INC has a market cap of $231.14 M.

In which sector does BIODESIX INC belong?

BIODESIX INC operates in the Diagnostics & Research sector.

What documents are required to invest in BIODESIX INC stocks?

To invest, you typically need:

What is the PE and PB ratio of BIODESIX INC?

The PE ratio of BIODESIX INC is N/A and the PB ratio is 24.10.